Skip to main content

Peer Review reports

From: A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

Original Submission
3 Jun 2008 Submitted Original manuscript
3 Jun 2008 Author responded Author comments - Peter Buchler
Resubmission - Version 2
3 Jun 2008 Submitted Manuscript version 2
14 Nov 2008 Reviewed Reviewer Report - Sjoerd Rodenhuis
19 Nov 2008 Author responded Author comments - Peter Buchler
Resubmission - Version 3
19 Nov 2008 Submitted Manuscript version 3
7 Jan 2009 Author responded Author comments - Peter Buchler
Resubmission - Version 4
7 Jan 2009 Submitted Manuscript version 4
Publishing
8 Jan 2009 Editorially accepted
8 Jan 2009 Article published 10.1186/1471-2482-9-1

You can find further information about peer review here.

Back to article page